FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
Articles
ADVM Stock Earnings: Adverum Biotechnologies Misses EPS for Q1 2024
ADVM stock results show that Adverum Biotechnologies missed analyst estimates for earnings per share the first quarter of 2024. More
CPHC Stock Earnings: Canterbury Park Holding Reported Results for Q1 2024
Canterbury Park Holding just reported results for the first quarter of 2024. More
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024
TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024
CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024
ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the second quarter of 2024. More
XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024
XNCR stock results show that Xencor missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
